These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1085 related articles for article (PubMed ID: 6891842)

  • 1. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo.
    Collen D; Rijken DC; Van Damme J; Billiau A
    Thromb Haemost; 1982 Dec; 48(3):294-6. PubMed ID: 6891842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
    Einarsson M; Brandt J; Kaplan L
    Biochim Biophys Acta; 1985 Jul; 830(1):1-10. PubMed ID: 4040396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tissue plasminogen activator].
    Matsuo O
    Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.
    Rijken DC; Juhan-Vague I; de Cock F; Collen D
    J Lab Clin Med; 1983 Feb; 101(2):274-84. PubMed ID: 6681623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of plasminogen activator in a melanoma cell line.
    Matsuo O; Sakai T; Matsuo C; Nishida Y; Akazawa K; Mihara H
    Acta Physiol Lat Am; 1983; 33(4):305-13. PubMed ID: 6377823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.
    Kruithof EK; Schleuning WD; Bachmann F
    Biochem J; 1985 Mar; 226(3):631-6. PubMed ID: 4039134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a melanoma cell plasminogen activator.
    Wallén P; Pohl G; Bergsdorf N; Rånby M; Ny T; Jörnvall H
    Eur J Biochem; 1983 May; 132(3):681-6. PubMed ID: 6682760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
    Rijken DC; Collen D
    J Biol Chem; 1981 Jul; 256(13):7035-41. PubMed ID: 6787058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent].
    Collen D
    Verh K Acad Geneeskd Belg; 1982; 44(5-6):295-305. PubMed ID: 6223460
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
    Heussen C; Joubert F; Dowdle EB
    J Biol Chem; 1984 Oct; 259(19):11635-8. PubMed ID: 6541221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of plasminogen activators by cultured bovine endothelial cells: partial purification, characterization and evidence for multiple forms.
    Laug WE
    Thromb Haemost; 1981 Jun; 45(3):219-24. PubMed ID: 7197062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of plasminogen activator from Rous sarcoma virus-infected chick embryo fibroblast culture medium.
    Kacian DL; Harvey RC
    Arch Biochem Biophys; 1985 Jan; 236(1):354-69. PubMed ID: 2981508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stability of tissue plasminogen activator (t-PA).
    Gaffney PJ; Templeman J; Curtis AD; Campbell PJ
    Thromb Haemost; 1983 Oct; 50(3):650-1. PubMed ID: 6685926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of tissue plasminogen activator by an enzyme-immunoassay method.
    Matsuo O; Kato K; Matsuo C; Matsuo T
    Anal Biochem; 1983 Nov; 135(1):58-63. PubMed ID: 6367540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.